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Resection offers the only chance of cure for patients with a carcinoma in the pancreatic head region. Despite the fact that mortality of subtotal pancreatoduodenectomy has decreased significantly in the past decade, postoperative morbidity is still considerable and can approach 50%. 1-3 Undertaking pancreatoduodenectomy for a pancreatic head tumor becomes even more a subject of discussion when histopathologic examination of the resected specimen may show benign disease, contrary to the preoperative diagnosis. A variety of lesions in the pancreatic head region can mimic a malignancy. 46 Particularly inflammatory lesions, such as in chronic pancreatitis, may display all the typical features of a carcinoma in preoperative imaging studies of the pancreas.
Of 220 consecutive pancreatoduodenectomies performed on the clinical suspicion of a pancreatic head carcinoma, 14 patients (6%) had, on histopathologic examination of the surgical specimen, a benign, inflammatory lesion of the pancreas or of the distal common bile duct (CBD). This subset of patients was analyzed for symptoms and diagnostic discriminating signs of chronic pancreatitis, gallstone disease, and pancreatic cancer. All clinical information and all radiographic images were critically reevaluated to determine an index of suspicion for cancer in each case. The definition of common features in this group of patients was thought to help us identify these pancreatic inflammatory lesions and, possibly, avoid unnecessary pancreatoduodenectomies.
PATIENTS AND METHODS
Preoperative diagnostic work-up of all patients presenting in our institution with a pancreatic head tumor routinely consists of abdominal ultrasound (US) with (color) Doppler flow assessment of the portal venous system and endoscopic retrograde cholangiopancreaticography (ERCP). Computed tomography (CT) has recently become a standard procedure in the preoperative workup of these patients but, in this study, was performed only in selected cases when US and ERCP were indeterminate. Visceral angiography and endoscopic ultrasonography (EUS) are only performed when there is reason for further investigation of vascular involvement or infiltration of the tumor into adjacent structures. When, by this staging procedure, no evidence is found for distant metastases or local tumor infiltration, patients are considered eligible for laparotomy and resection of the tumor with curative intent. In patients with jaundice, a biliary endoprosthesis for preoperative drainage of the biliary system is inserted at the time of diagnostic ERCP.
Between 1983 and 1993, 220 patients (median age 62 years) underwent a subtotal pancreatoduodenectomy (Whipple's resection, n = 188) or a total pancreatectomy (n = 32) on the suspicion of a pancreatic head cancer, based on clinical presentation and imaging studies. In 14 of these patients (seven men and seven women, median age 53 years), histopathologic analysis of the specimen showed a benign, inflammatory lesion diagnosed as chronic pancreatitis of varying severity or as chronic inflammation of the distal CBD. The medical files and radiographic material of these 14 patients were reassessed. The clinical history was reevaluated with special attention to features specific for benign or malignant pancreatic disease1: previous chronic pancreatitis, alcohol abuse, pain symptoms, weight loss, endocrine and exocrine pancreatic function, jaundice, and gallstone disease.
All radiographic films were reexamined by a blinded panel consisting of a surgeon, gastroenterologist, and radiologists, all of whom are experienced in hepatopancreatobiliary disorders. Criteria were defined for signs on US and ERCP which, either alone or in combination, are characteristic of malignancy or chronic pancreatitis. 7-1° The suspicion for malignancy resulting from each investigation was graded on a 0/+/++ scale: no suspicion = 0, suspicious = +, highly suspicious = + +. On the basis of reassessment of all clinical and radiographic data, an overall index of suspicion for malignancy was determined for each case by weighing the suspicion scores of all investigations in one patient. Thus, the final suspicion score in each patient was not derived from the exact mean or sum of scores of the individual tests but was based on the investigations giving the highest suspicion. Histopathologic analysis of the resected specimens reported as benign was reconfirmed by an experienced histopathologist.
RESULTS

Clinical presentation
Pain, usually vague upper abdominal pain of recent onset, was present in 11 of 14 patients. None of the patients had severe, persistent pain that required narcotic analgesics. In only one patient, a diagnosis of chronic pancreatitis associated with alcohol abuse had been made previously. This patient was free of symptoms for many years after cessation of drinking. Another patient had a history of increased alcohol consumption. Weight loss, ranging from 2 to 20 kg, was noted in 9 of 14 patient s. Seven of fourteen patients were clinically jaundiced at first presentation. The duration of symptoms was short (1 to 3 months) in all but one patient with a history of 6 months. Two patients had diabetes mellitus, one requiring insulin therapy. None of the patients had steatorrhea or needed pancreatic enzymes. The recent onset and type of symptoms were considered suspicious for malignant disease in 12 of 14 patients (+ in five patients and + + in seven patients).
US
US findings included four patients with a dilated CBD (> 7 mm) as well as pancreatic duct (PD, > 2 mm), whereas in the remaining 10 patients, either the CBD or the PD was dilated. A solitary, hypoechogenic mass lesion was defined in the pancreatic head in 12 patients (mean tumor size: 2.8 cm). In two patients who had no detectable tumor on US, a tumor (1.5 cm and 2 cm in diameter, respectively) was palpated in the pancreatic head during surgery. A Doppler shift was found at (color) Doppler flow assessment of the portal venous system in one patient at some distance from the tumor site. Signs of chronic pancreatitis (calcifications featuring acoustic shadowing) were noted in 4 of 14 patients. With the use of US, 12 cases were found to be suspicious of malignancy (+ in four patients and + + in eight patients); in one patient, findings were compatible with chronic pancreatitis and in one patient, no abnormalities of the pancreas were noted. In the latter two cases, the decision to perform resection was based on clinical presentation and the suspicion raised by the ERCP images.
ERCP
The ERCP findings are summarized in Table 1 . In one patient (case No. 6), retrograde cannulation of the papilla of Vater failed, and no images of the CBD or the PD were obtained. In two patients (case Nos. 1 and 14), the PD was not adequately visualized because of incomplete filling of the duct. Of 11 patients, five had a typical "double duct" sign, that is, a distal stenosis of both the CBD and PD (Fig. 1 ). In 9 of 13 patients, a distal CBD stenosis was present ~4th a length ranging from i to 4 cm (mean: 1.9 cm) and with one or more features suggestive of malignancy (irregular narrowing, shouldering sign, eccentric configuration) (Fig. 2) . In one patient (case No. 10), stenosis of the CBD did not result in proximal dilatation of the biliary tree. A stenosis (length 1 to 5 cm) or complete obstruction of the PD was shown in 10 of 11 patients in which the PD was successfully opacified. The PD distal to the lesion did not show any accompanying radiographic signs of chronic pancreatitis in these patients. In all but one patient presenting with a CBD stenosis, the biliary tract was drained during the ERCP procedure, either by positioning of an endoprosthesis (seven patients) or by sphincterotomy only (one patient). Of the 13 patients who had undergone ERCP, five patients were considered suspicious (+) and eight patients highly suspicious (+ +) of having a cancer in the pancreatic head.
Overall index of suspicion, intraoperative findings, and pathology results
Taking together the reassessments of clinical presentation and of the US and ERCP images, we determined the overall index of suspicion for cancer for each patient, as shown in Table 2 . Agreement was unanimous among surgeon, gastroenterologist, and radiologists with respect to seven cases being classified as suspicious (+) and seven cases as highly suspicious (+ +) for cancer. Although at the outset of this study criteria were set for suspicious clinical and radiologic features, it proved to be difficult to achieve a final suspicion score based on calculation of the separate scores of each case. Suspicion clearly was based on objective criteria and interpretation of a whole set of results.
At laparotomy, a frank tumor measuring 1.5 to 4 cm was identified in the pancreatic head in nine patients, whereas in the other four patients, the pancreatic head was noted to be diffusely enlarged (in one patient, pancreatic head size was not specifled). No attempt was made to obtain a biopsy sample from the lesion in any of the patients during operation, following the policy in our department. Pancreatoduodenectomy was performed in all 14 patients without mortality (30-day mortality and hospital mortality in all 220 patients was 2.3% and 6.4%, respectively). Major postoperative complications were noted in 3 of the 14 patients: acute pancreatitis of the pancreas remnant requiring relaparotomy and two intraabdominal abscesses, one of which was managed percutaneously. At follow-up, 3 to 6.5 years after the primary operation, none of the patients showed signs of a malignant process in the previous operative field.
Full histopathologic review of the surgical specimens showed varying degrees of a chronic fibrosing pancreatitis in 12 patients and chronic fibrosing inflammation of the distal CBD in two patients (Table 2) . Focal epithelial dysplasia of ducts was noted in only one of the 14 patients.
DISCUSSION
Pancreatic carcinoma and benign, inflammatory lesions of the pancreas, notably in chronic pancreatitis, may present with the same symptoms and signs. Furthermore, the differential diagnosis of both conditions is complex because pancreatic cancer is frequently associated with secondary inflammatory changes caused by obstruction of the PD, 5' 11 whereas chronic pancreatitis may develop into pancreatic carcinoma. 12-14 A combination of different imaging modalities is usually applied in the diagnosis of pancreatic head lesions to improve diagnostic accuracy. ~5 Of all imaging techniques, however, there is not one single investigation that can reliably discriminate between chronic pancreatitis and pancreatic cancer.
Pancreatic head cancer encompasses mainly carcinomas of the pancreatic duct, the distal bile duct, and ampullary carcinomas. 1' 1G The "double duct" lesion, that is, a stenosis of the CBD and the PD, is a characteristic, radiologic finding in pancreatic head cancer. 7-1° However, depending on the site of origin in the pancreatic head, a distal bile duct carcinoma may also present as a single stenosis of the CBD and a PD carcinoma as a single stenosis of the PD. Hence, in the absence of previous pancreatic or biliary tract surgery, any stenosis of the CBD or PD, being single or double, carries a risk of harboring a cancer. In this series, 5 of 12 evaluable patients had a typical "double duct" sign. The other patients had either a single stenosis of the CBD or of the PD.
Chronic pancreatitis usually causes stricturing of the pancreatic ductal system and may present either as a single stenosis or as multiple stenoses of the PD. 17 An irregular stenosis of the PD > 10 mm, is considered highly suspicious of cancer. 13 Ten of eleven patients in this study had at ERCP, a stenosis of 1 to 5 cm in length (seven patients) or a complete obstruction of the PD (three patients). Inflammatory conditions involving the pancreatic head can also give rise to stricturing of the CBD. 7, ls-2o Biliary strictures have been reported to occur in 25% up to as high as 69% of patients with chronic pancreatitis. These bile duct stenoses usually are incomplete, longer (1 to 7 cm), tapered, and smoothly delineated in comparison with stenoses caused by pancreatic cancer. In the present series, 9 of 13 evaluable patients had a stenosis of the distal CBD, with a mean length of 1.9 cm. Although CT imaging has recently been added to the standard preoperative workup of patients with pancreatic tumors in our institution, CT was performed only in selected cases during the period of this study. Evaluation of CT data in a recent series of patients with pancreatic tumors, however, did not appear to add much to the conclusions derived from US investigations (study in progress). An important point in this regard is the quality of ultrasound investigations, which obviously is operator dependent and requires expertise, especially in the assessment of biliary and pancreatic disorders. Although CT can be highly accurate in predicting resectable or unresectable disease in pancreatic cancer, 21 the technique is less reliable in the differential diagnosis of pancreatic cancer and chronic pancreatitis. 22 Differentiation of chronic pancreatitis and pancreatic cancer by CT may even be impossible because pancreatic carcinoma can be associated with inflammatory disease. 2~ The accuracy rate of CT was 77% in a prospective study by DelMaschio et al., 24 in which the value of CT was assessed in 81 consecutive patients with suspected pancreatic cancer or chronic pancreatitis. Analyzing the collective published data, RSsch and Classen 25 found the accuracy of CT to be 53% in the differential diagnosis of malignancy and focal chronic pancreatitis.
EUS is not routinely applied in the diagnosis of benign and malignant disorders of the pancreas in our institution because it was not found to provide VOLUME 46, NO, 5, 1997 GASTROINTESTINAL ENDOSCOPY 421 more information than obtained with conventional, transabdominal US. In an analysis of collective published data, the accuracy of EUS in the differential diagnosis between malignancy and focal chronic pancreatitis was 61%. 25 Recent innovations in magnetic resonance imaging (MRI) have permitted improved depiction of the pancreas. Nonenhanced FLASH (fast, low-angle shot) imaging and gadolinium-enhanced FSSE (fat-suppressed spin-echo) imaging seem to be promising techniques to distinguish inflammatory disease from pancreatic cancer and may be useful in situations in which CT findings are indeterminate. 26 Serum CA 19~9, although claimed to be a sensitive and specific tumor marker for pancreatic cancer, may be influenced by extrahepatic cholestasis and active pancreatitis, limiting its use as a discriminative test. 24 ' 27, 28 Obviously, excision of the lesion is the only way to rule out malignancy at the price of performing pancreatoduodenectomy for a benign condition. Preoperative, fine-needle aspiration biopsy may provide evidence of malignancy but carries a potential risk of implantation metastases. 2~-31 In addition, false negative results caused by sampling errors, as high as 60%, should be taken into account when performing fine-needle aspiration biopsy. 32' 33 Even if sampling of the neoplastic sites in the tumor can be improved by advanced techniques, the histopathologic differentiation between inflammatory lesions and malignant disease can be difficult, particularly in well-differentiated pancreatic cancers. Molecular markers as K-ras mutations and p53 could potentially increase the diagnostic yield of cytologic aspiration biopsies, but, clinical application awaits further assessments. 34 For these reasons, we do not routinely obtain a biopsy sample from an otherwise resectable pancreatic lesion, but proceed with resection.
Pancreatoduodenectomy is the standard operation for pancreatic head cancer and, in addition, has been successfully performed for a variety of diseases including advanced chronic pancreatitis localized in the pancreatic heady Pancreatoduodenectomy performed for a benign lesion that was suspected to be a carcinoma has sporadically been reported in the literature, as reviewed by Cohen et al. 4 They found 52 cases of pancreatoduodenectomies inadvertently performed for benign conditions including cystadenoma and a myoblastoma of the pancreas. With respect to larger series of pancreatoduodenectomies, the incidence of resecting a lesion that turned out to be benign was 3% to 5%. 4-6 The present report focuses on benign, inflammatory lesions in the pancreatic head that were misdiagnosed as pancreatic cancer. In this series, the incidence of finding such a benign lesion was 6%. Careful review of all preoperative information and radiographic images confirmed the suspicious presentation of these benign cases. The decision to undertake resection at the time of initial evaluation, therefore, was not an error in judgement, but reflects a consistent policy in the management of pancreatic head tumors.
Pancreatitis and biliary tract disease account for most inflammatory lesions in the pancreatic head. In this series, 12 patients were diagnosed, histopathologically, as active chronic pancreatitis of varying severity, whereas two patients had a normal pancreas but had inflammatory changes of the distal CBD. Although the latter two patients had no history of gallstone disease or evidence of gallstones in the preoperative investigations, stone passage through the distal CBD and papilla is the most likely cause of the observed inflammatory lesions. Epithelial dysplasia of pancreatic ducts was not present except for one patient ( Table 2 , case No. 3), in which focal epithelial dysplasia was found in conjunction with chronic, locally active fibrosing pancreatitis.
In conclusion, considering the improved results of pancreatoduodenectomy, resection of any lesion suspicious of pancreatic head cancer is justified in specialized centers, lest a potentially curable cancer be missed. However, a consequence of this policy is that, in at least 5% of cases, a benign, inflammatory lesion masquerading as pancreatic cancer may be diagnosed by histopathologic analysis of the surgical specimen.
